Ali Radfar

Ali Radfar, M.D., a former venture capitalist, equity research analyst, and investment banker, with over $7.5B USD relevant transactional expertise in M&A, IPOs, and Private Placements within the Device, Instrumentation, and Biopharmaceutical sectors rounds out the management team as CFO.